Gilada Finance & Investments Intrinsic Value

Gilada Finance & Investments (GILADAFINS) median intrinsic value is ₹24.98 from 9 valuation models (range ₹10–₹35), vs current price ₹12.49 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit GILADAFINS share price.

Current Stock Price
₹12.49
Primary Intrinsic Value
₹19.20
Market Cap
₹8.7 Cr
+100.0% Upside
Median Value
₹24.98
Value Range
₹10 - ₹35
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

GILADAFINS Valuation Methods Summary — DCF, Graham Number & P/E

Gilada Finance & Investments intrinsic value across 9 models vs current price ₹12.49 — upside/downside and value range per method. Browse Gilada Finance & Investments financial data for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹19.20 ₹15.36 - ₹23.04 +53.7% EPS: ₹1.60, Sector P/E: 12x
Book Value Method asset ₹27.43 ₹24.69 - ₹30.17 +119.6% Book Value/Share: ₹34.29, P/B: 0.8x
Revenue Multiple Method revenue ₹10.00 ₹9.00 - ₹11.00 -19.9% Revenue/Share: ₹10.00, P/S: 1.0x
EBITDA Multiple Method earnings ₹24.98 ₹22.48 - ₹27.48 +100.0% EBITDA: ₹4.00Cr, EV/EBITDA: 5x
Simple DCF (5Y) dcf ₹31.23 ₹24.98 - ₹37.48 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹10.24 ₹9.22 - ₹11.26 -18.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹13.76 ₹12.38 - ₹15.14 +10.2% Revenue Growth: 15.0%, Adj P/E: 8.6x
ROE Based Valuation profitability ₹24.98 ₹22.48 - ₹27.48 +100.0% ROE: 8.3%, P/E Multiple: 10x
Graham Defensive Method conservative ₹35.13 ₹31.62 - ₹38.64 +181.3% EPS: ₹1.60, BVPS: ₹34.29
Method Types: Earnings Asset DCF Growth Dividend Conservative

GILADAFINS Intrinsic Value vs Market Price — All Valuation Models

Gilada Finance & Investments fair value range ₹10–₹35 vs current market price ₹12.49 across 9 valuation models. Also explore Gilada Finance & Investments share price performance to track price trends across different timeframes.

GILADAFINS Intrinsic Value Analysis — Undervalued or Overvalued?

Gilada Finance & Investments median intrinsic value ₹24.98, current price ₹12.49 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of GILADAFINS?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gilada Finance & Investments (GILADAFINS) is ₹24.98 (median value). With the current market price of ₹12.49, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹10.00 to ₹35.13, indicating ₹10.00 - ₹35.13.

Is GILADAFINS undervalued or overvalued?

Based on our multi-method analysis, Gilada Finance & Investments (GILADAFINS) appears to be trading below calculated value by approximately 100.0%.

GILADAFINS Financial Health — Key Ratios vs Industry Benchmarks

Gilada Finance & Investments financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.10 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Return on Equity 8.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 58.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.20x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

GILADAFINS Cash Flow Quality — Operating & Free Cash Flow

Gilada Finance & Investments operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2024 ₹-7 Cr ₹-7 Cr Negative Cash Flow 3/10
March 2023 ₹-3 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2022 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10